Skip to main content
Log in

Effect of aspirin on gallbladder motility in patients with gallstone disease

A randomized, double-blind, placebo-controlled trial of two dosage schedules

  • Pancreatic and Biliary Disorders
  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Abstract

Patients with gallstone disease have impaired gallbladder motility. Prostaglandins are thought to be important mediators of gallbladder hypomotility. We assessed the effect of aspirin, a prostaglandin inhibitor on gallbladder resting volume and ejection fraction according to a double-blind study protocol in 20 healthy volunteers and 30 patients with gallstone disease. Healthy volunteers had a higher ejection fraction compared to patients with gallstone disease (73.9±0.9% vs 60.4±1.0%,P<0.05). Aspirin in a dose of 350 mg/day for two weeks did not alter gallbladder motility in the healthy volunteers. Thirty patients with gallstone disease were randomized into three treatment groups: group I (placebo), group II (aspirin 350 mg/day), and group III (aspirin 1400 mg/day). After two weeks of treatment, gallbladder ejection fraction was improved in group II (74.0±1.7% vs 62.0±1.7%,P<0.01) and group III (69.8±3.8% vs 61.2±1.3%,P<0.01) but not in group I (60.4±2.6% vs 59.0±1.9%,P=NS). The higher dose of aspirin did not induce a greater increase in gallbladder emptying. It is concluded that impaired gallbladder motility in patients with gallstone disease is corrected by short-term oral aspirin even in low dosage. This may be clinically useful in secondary prophylaxis after nonsurgical therapy for gallstone disease.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Fisher RS, Stelzer F, Rock E, Malmud LS: Abnormal gallbladder emptying in patients with gallstones. Dig Dis Sci 27:1019–1024, 1982

    Google Scholar 

  2. Masclee AAM, Jansen JBMJ, Driessen WMM, Gueskens LM, Lamers CBHW: Plasma cholecystokinin responses to intraduodenal fat in gallstone patients. Dig Dis Sci 34:353–359, 1989

    Google Scholar 

  3. Doty JE, Pitt HA, Kuchewbecker SL, Den Basten L: Impaired gallbladder emptying before gallstone formation in the prairie dog. Gastroenterology 85:168–174, 1983

    Google Scholar 

  4. Behar J, Lee KY, Thompson WR, Biancani P: Gallbladder contraction in patients with pigment and cholesterol stones. Gastroenterology 97:1479–1484, 1989

    Google Scholar 

  5. Friedhandler TM, Davison JS, Shaffer EA: Defective gallbladder contractility in the ground squirrel and prairie dog during early stages of cholesterol gallstone formation. Gastroenterology 85:830–836, 1983

    Google Scholar 

  6. Li YF, Weisbrodt NW, Moody FG, Coelho JC, Gouma DJ: Calcium induced contraction and contractile protein content of gallbladder smooth muscle after high cholesterol feeding of prairie dogs. Gastroenterology 92:746–750, 1987

    Google Scholar 

  7. LaMont JT, Turner BS, DiBenedetto D, Handin R, Schafer AI: Arachidonic acid stimulates mucin secretion in prairie dog gallbladder. Am J Physiol 245:92–98, 1983

    Google Scholar 

  8. Hood K, Glesson D, Ruppin DC, Dowling RH: Prevention of gallstone recurrence by nonsteroidal antiinflammatory drugs. Lancet 332:1223–1225, 1988

    Google Scholar 

  9. Broomfield RH, Chopra R, Sheinbaum RC, Bonorris G, Silvermat A, Bush M, Gilman L, Komaiko M, Schenfield LJ: Effects of Ursedeoxycholic acid and aspirin on the formation of lithogenic bile and gallstones during loss of weight. N Engl J Med 319:1567–1572, 1988

    Google Scholar 

  10. Lee SP, Carey MC, LaMont JT: Aspirin prevention of cholesterol gallstone formation in prairie dogs. Science 211:1429–1431, 1981

    Google Scholar 

  11. O'Donnell LJD, Wilson P, Guest P, Catnach SM, Mclean A, Wickham JEA, Fairclough PD: Indomethacin and postprandial gallbladder emptying. Lancet 339:261–271, 1992

    Google Scholar 

  12. Murray FE, Stinchcombe SJ, Hawkey CJ: Effect of indomethacin and misoprostol on fasted gallbladder volume and meal-induced gallbladder contractility in humans. Dig Dis Sci 37:1228–1231, 1992

    Google Scholar 

  13. Jonderko G, Jonderko K, Konca A, Polko M: Effect of a synthetic prostaglandin E1 derivative, misoprostol on fasted gallbladder emptying in man. Am J Gastroenterol 84:1375–1379, 1989

    Google Scholar 

  14. UK-TIA Study Group: United Kingdom transient ischemic attack (UK-TIA) aspirin trial: Interim results. BMJ 296:316–320, 1988

    Google Scholar 

  15. Paul AI: Analgesic-antipyretic and antiinflammatory agents; drugs employed in the treatment of rheumatoid arthritis and gout.In The Pharmacological Basis of Therapeutics. 8th ed. AG Gilman, TW Rall, AS Nies, P Taylor (eds). New York, Pergamon Press, 1990, pp 638–681

    Google Scholar 

  16. Dodds WJ, Groh WJ, Darweesh RMA, Lawson TL, Kirsk SMA, Kern MK: Sonographic measurement of gallbladder volume. Am J Roentgenol 145:1009–1011, 1985

    Google Scholar 

  17. Everson GT, Braverman DZ, Johnson ML, Kern F Jr: A critical evaluation of realtime ultrasonography for the study of gallbladder volumes and contraction. Gastroenterology 79:40–46, 1980

    Google Scholar 

  18. Catnach SM, Fairclough PD, Trembath RC, O'Donnell LJD, McLean AM, Law PA, Wickham JEA: Effect of oral erythromycin on gallbladder motility in normal subjects and subjects with gallstones. Gastroenterology 102:2071–2076, 1992

    Google Scholar 

  19. Behar J, Biancani P: Pharmacology of biliary tract.In Handbook of Physiology, Section 6. The Gastrointestinal System, Vol 1. G. Schultz (ed). New York, Oxford University Press, 1989, pp 1103–1131

    Google Scholar 

  20. Chapman WC, Lamonte WW, Williams FF: Alternation of biliary motility correlate with increased gallbladder prostaglandin synthesis in early cholelithiasis in prairie dogs. Dig Dis Sci 34:1420–1424, 1989

    Google Scholar 

  21. Nakano J, Gin AC, Nakano SK, Effect of prostaglandin E1, E2 and F2 on the gallbladder pressure in dogs. Eur J Pharmacol 30:107–112, 1975

    Google Scholar 

  22. Carey MC, Cahalane MJ: Whither biliary sludge? Gastroenterology 195:508–523, 1988

    Google Scholar 

  23. Pomeranz IS, Shaffer EA: Abnormal gallbladder emptying in a subgroup of patients with gallstones. Gastroenterology 88:787–791, 1985

    Google Scholar 

  24. Hutton SW, Sievert CE Jr, Vennes JA, Shafer RB, Duane WC: Spontaneous passage of glass beads from the canine gallbladder: Facilitation by sphincterotomy: Gastroenterology 94:1031–1035, 1988

    Google Scholar 

  25. Cotton PB, Vallon AG: Duodenoscopic sphincterotomy for removal of bile duct stones in patients with gallbladders. Surgery 91:628–630, 1982

    Google Scholar 

  26. O'Donnell LJD, Heaton KW: Recurrence and re-recurrence of gallstones after medical dissolution: A long term follow up. Gut 29:655–658, 1988

    Google Scholar 

  27. Xu QW, Shaffer EA: Cisapride improves gallbladder contractility and bile lipid composition in an animal model of gallstone disease. Gastroenterology 105:1184–1191, 1993

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Das, A., Baijal, S.S. & Saraswat, V.A. Effect of aspirin on gallbladder motility in patients with gallstone disease. Digest Dis Sci 40, 1782–1785 (1995). https://doi.org/10.1007/BF02212702

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02212702

Key Words

Navigation